Cite

HARVARD Citation

    Luabeya, A. et al. (2015). First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Vaccine. 33 (33), pp. 4130-4140. [Online]. 
  
Back to record